United States · FDA National Drug Code directory

ZYPITAMAG

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
70771-1118_8eab99e7-f5e0-4b8a-8cc6-2d90618ebf93
Product NDC
70771-1118
Form
TABLET, FILM COATED
Composition / generic term
Pitavastatin Magnesium
Labeler
Zydus Lifesciences Limited
Marketing category
NDA
Marketing start / end (source format)
20180309
Source listing expiry
20261231

Source-listed ingredients

  • PITAVASTATIN — 4 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1000 TABLET, FILM COATED in 1 BOTTLE (70771-1118-0) · 70771-1118-0
  • 100 TABLET, FILM COATED in 1 BOTTLE (70771-1118-1) · 70771-1118-1
  • 30 TABLET, FILM COATED in 1 BOTTLE (70771-1118-3) · 70771-1118-3
  • 10 BLISTER PACK in 1 CARTON (70771-1118-4) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 70771-1118-4
  • 500 TABLET, FILM COATED in 1 BOTTLE (70771-1118-5) · 70771-1118-5
  • 1 BLISTER PACK in 1 CARTON (70771-1118-7) / 7 TABLET, FILM COATED in 1 BLISTER PACK · 70771-1118-7
  • 90 TABLET, FILM COATED in 1 BOTTLE (70771-1118-9) · 70771-1118-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →